2016
DOI: 10.1007/s11011-016-9857-3
|View full text |Cite
|
Sign up to set email alerts
|

Safflower yellow ameliorates cognition deficits and reduces tau phosphorylation in APP/PS1 transgenic mice

Abstract: Alzheimer's disease (AD), the most common cause of dementia worldwide, is mainly characterized by the aggregated β-amyloid (Aβ) and hyperphosphorylated tau. Safflower yellow (SY) is a novel water extract of natural safflower and has been suggested to ameliorate memory deficits in several animal models of dementia. In this study, we aimed to investigate the effect and mechanism of SY on deficits of learning and memory and hyperphosphorylation of tau in APP/PS1 double transgenic mice. APP/PS1 mice were administe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 37 publications
2
5
0
Order By: Relevance
“…Numerous studies have observed that the phosphorylation of some sites of tau is significantly increased in APP/PS1 mice despite the lack of mature tangles. 51 , 52 , 53 Consistent with previous studies, we found that the level of tau phosphorylation at Thr181 and Ser396 was increased in the hippocampus (Figure 6B,D ) and cortex (Figure 6F,H ) of the APP/PS1 mice, but similar results were not observed for tau phosphorylation at Ser202 (Figure 6C,G ). The role of HDAC2/3 in tau pathway is not well‐defined.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Numerous studies have observed that the phosphorylation of some sites of tau is significantly increased in APP/PS1 mice despite the lack of mature tangles. 51 , 52 , 53 Consistent with previous studies, we found that the level of tau phosphorylation at Thr181 and Ser396 was increased in the hippocampus (Figure 6B,D ) and cortex (Figure 6F,H ) of the APP/PS1 mice, but similar results were not observed for tau phosphorylation at Ser202 (Figure 6C,G ). The role of HDAC2/3 in tau pathway is not well‐defined.…”
Section: Discussionsupporting
confidence: 91%
“…Numerous studies have observed that the phosphorylation of some sites of tau is significantly increased in APP/PS1 mice despite the lack of mature tangles. [51][52][53] Consistent with previous studies, we found that the level of tau phosphorylation at Thr181…”
Section: Apicidin Treatment Does Not Reduce Tau Phosphorylation In Th...supporting
confidence: 92%
“…Hyperphosphorylated tau is the primary component of intracellular NFTs, which have an important role in AD pathology ( 2 , 39 ). It has been demonstrated that hyperphosphorylated tau may also result in neuronal death and memory impairment ( 5 , 40 , 41 ). A number of serine phosphorylation sites of tau are elevated in AD mice, including Ser199 and Ser396 ( 42 ).…”
Section: Discussionmentioning
confidence: 99%
“…Pathologically, accumulation of senile plaques, neurofibrillary tangles (NFTs) and neuronal loss have been observed in the brain cortex and hippocampus of patients with AD ( 2 ). Although the underlying mechanisms have not been fully elucidated, β-amyloid (Aβ) aggregation and tau hyperphosphorylation have been revealed to exhibit key roles in the pathogenesis of AD ( 3 , 4 ), as they are primary components of senile plaques and NFTs, respectively ( 5 , 6 ) and are associated with neuronal loss and memory deficits ( 7 , 8 ). Therefore, potential pharmacological agents targeting the inhibition of these pathological processes may be promising therapeutic approaches in treating AD.…”
Section: Introductionmentioning
confidence: 99%
“…The step-down test was performed as described by Ruan et al (2016) . The error times during training, step-down delay and error times during experiments were recorded.…”
Section: Methodsmentioning
confidence: 99%